Category Archives: Strategy

Sparks Fly at Prix Galien Forum on US Health Reform

Last week’s Prix Galien Forum on global issues in life sciences was not without controversy. The absence of to be ousted Sanofi chief Christopher Viehbacher loomed over the event and notably on the day’s most contentious panel on US Healthcare Reform. Standing in for Viehbacher on the panel was Elias Zerhouni, President, Global R&D for […]
Also posted in Events, leadership | Leave a comment

The Pharma Leadership Challenge: Thawing the “Frozen” Middle Managers

The challenge for senior leadership is to enable the layers of middle management to work to their full potential. Mike Straw argues that ‘failing fast’ should become the new mantra if pharma is going to drive greater innovation and creativity. J. Michael Pearson, CEO of Valeant, the Canadian based speciality drugmaker, recently said that “the […]
Also posted in Guest Blog, leadership | Tagged , , | 1 Comment

Viehbacher Exits Sanofi

Christopher A. Viehbacher resigned as director of Sanofi immediately after its Board of Directors unanimously agreed to remove him as the company’s CEO yesterday. Chairman Serge Weinberg will replace Viehbacher on an interim basis.
Also posted in Europe, Global, leadership | Tagged , | Leave a comment

NHL Treatment Market Boom Will Be Hindered in EU

The global non-hodgkin lymphoma (NHL) treatment market will increase in value from $5.6 billion in 2013 to $9.2 billion by 2020, according to GBI Research.
Also posted in Europe, R&D | Tagged , , , , , , | Leave a comment

Gilead and Yale Extend Sequencing Initiative

After having already sequenced thousands of cancer genes in projects together, the Yale School of Medicine and Gilead announced they will continue their partnership to find therapeutic candidates for cancer for an additional three years. The original agreement was forged in 2011 and can be renewed for up to 10 years.
Also posted in R&D, Technology | Tagged , | Leave a comment
  • Categories

  • Meta